AMENDMENT NO. 2 TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT

EX-4.1.2 3 a2206216zex-4_12.htm EX-4.1.2

Exhibit 4.1.2

 

AMENDMENT NO. 2

 

TO

 

AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT

 

This Amendment No. 2 to Amended and Restated Stockholders’ Agreement (this “Amendment”), is made and entered into effective as of November 7, 2011, by and among Radius Health, Inc., a Delaware corporation (the “Company”), and the undersigned stockholders of the Company party to the Amended and Restated Stockholders’ Agreement, dated as of May 17, 2011, by and among the Company and the stockholders named therein (as amended, the “Agreement”).  All capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Agreement.

 

WHEREAS, the Company and the undersigned parties to the Agreement, comprising the Majority Investors, desire to (i) amend the Agreement in order to specify restrictions on the sale by Stockholders of shares of the Company’s capital stock, (ii) confirm that the Company has complied with its obligations under the Agreement relating to the Registration Statement on Form S-1 (Reg. No. 333-175091) originally filed with the Commission on June 23, 2011 (as amended, the “Form S-1”), (iii) in accordance with its obligations to two option holders, grant certain registration rights under the Agreement to such individuals and (iv) permit additional holders of the Company’s securities to become parties to, and subject to, the Agreement.

 

NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.             Clause (C) of Section 3.11(b) of the Agreement is hereby amended and restated in its entirety to read as follows:

 

“(C) in no event shall any Stockholder be permitted, during the period commencing on the date hereof and ending on the date of the listing of the Common Stock on a national securities exchange, to sell, assign, transfer, make a short sale of, loan, grant any option for the purchase of, any shares of Common Stock for a price that is less than $8.142 per share (subject to proportionate and equitable adjustment upon any stock split, stock dividend, reverse stock split or similar event affecting the Common Stock that becomes effective after the date of this Agreement) or any other shares of capital stock of the Company for an effective price that is less than $8.142 per share on an as-converted to Common Stock basis (subject to proportionate and equitable adjustment upon any stock split, stock dividend, reverse stock split or similar event affecting the Common Stock that becomes effective after the date of this Agreement), except (x) with the prior written consent of the Company or (y) to a member of such Stockholder’s Group.”

 

2.             Upon, and subject to, the effectiveness of the Form S-1 on or prior to November 14, 2011, the Company shall have complied with all of its obligations under Section 3.4(a)(ii) of the Agreement with respect to the Registration Statement, no Event shall have occurred and the Company shall have no liability or obligation to pay any damages under the Agreement with

 



 

respect to such Registration Statement.  Notwithstanding the terms of Section 3.4(a)(iii), the Registrable Securities to be included in the Registration Statement shall be allocated in the manner they will have been allocated in the Form S-1.

 

3.             Solely of the purposes of Sections 3.4 through 3.12 of the Agreement, the shares of Common Stock issuable upon the exercise of the stock options issued to Alan H. Auerbach prior to the date hereof or upon the exercise of any stock options issued to Kurt C. Graves prior to November 30, 2011 shall be Registrable Securities as if such shares of Common Stock were Series A-1 Conversion Shares, and shall engender to each of Mr. Auerbach and Mr. Graves, as the case may be, the rights and obligations under the terms of Sections 3.4 through Section 3.12 of the Agreement (but not any other section of the Agreement) attributable to holders of Series A-1 Preferred Stock.

 

4.             Notwithstanding anything in the Agreement to the contrary, any holder of shares of capital stock of the Company or other securities of the Company may become a party to the Agreement following the delivery to, and written acceptance by, the Company of an executed Instrument of Adherence to the Agreement substantially in the form attached to the Agreement as Annex C.  No action or consent by Stockholder parties to the Agreement shall be required for such joinder to the Agreement by such holder, so long as such holder has agreed in writing to be bound by all of the obligations as a Stockholder party under the Agreement as indicated in the Instrument of Adherence and the Instrument of Adherence has been accepted by the Company.  Notwithstanding anything in the Agreement to the contrary, any holder of shares of capital stock of the Company or other securities of the Company may become a party to the Agreement by executing and delivering to the Company this Amendment, and no action or consent by Stockholder parties to the Agreement shall be required for such joinder to the Agreement.

 

5.             Each party to this Amendment that was not a party to the Agreement prior to its execution of this Amendment (an “Additional Party”) hereby agrees that such Additional Party, (i) in the case of a holder of Common Stock, has become a party and subject to the Agreement (as amended by this Amendment) in the capacity of a Common Stockholder and Stockholder, (ii) in the case of a holder of an option to purchase Common Stock, effective upon the exercise of such option, shall be a party and subject to the Agreement (as amended by this Amendment) in the capacity of a Common Stockholder and Stockholder, (iii) in the case of a holder of a warrant to purchase shares of Preferred Stock, effective upon the exercise of such warrant, shall be a party and subject to the Agreement (as amended by this Amendment) in the capacity of a Stockholder, and in each case shall be deemed to have made all of the representations and warranties made by a Stockholder under the Agreement.

 

6.             Except as modified by this Amendment, the Agreement is hereby reaffirmed in its entirety by the Stockholders and shall continue in full force and effect.  This Amendment shall be construed and enforced in accordance with and governed by the laws of the Commonwealth of Massachusetts, without giving effect to the principles of conflicts of laws thereof that would result in the application of the laws of any other jurisdiction.  This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

[remainder of page intentionally left blank; signatures follow]

 



 

IN WITNESS WHEREOF, each of the undersigned has caused this Amendment to be duly executed on its behalf as of the day and year first above written.

 

 

 

RADIUS HEALTH, INC.

 

 

 

 

 

 

 

 

By:

/s/ C. Richard Edmund Lyttle

 

 

 

C. Richard Edmund Lyttle, President

 

 

 

STOCKHOLDERS:

 

 

 

 

 

MPM BIOVENTURES III, L.P.

 

 

By:

MPM BioVentures III GP, L.P., its General Partner

 

 

By:

MPM BioVentures III LLC, its General Partner

 

 

 

 

 

By:

/s/ Ansbert K. Gadicke

 

 

 

Ansbert K. Gadicke, Series A Member

 

 

 

 

 

MPM BIOVENTURES III-QP, L.P.

 

 

By:

MPM BioVentures III GP, L.P., its General Partner

 

 

By:

MPM BioVentures III LLC, its General Partner

 

 

 

 

 

 

By:

/s/ Ansbert K. Gadicke

 

 

 

Ansbert K. Gadicke, Series A Member

 

 

 

 

 

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

 

 

By:

MPM BioVentures III GP, L.P., in its

 

 

 

capacity as the Managing Limited Partner

 

 

By:

MPM BioVentures III LLC, its General Partner

 

 

 

 

 

 

By:

/s/ Ansbert K. Gadicke

 

 

 

Ansbert K. Gadicke, Series A Member

 

 

 

 

 

MPM BIOVENTURES III PARALLEL FUND, L.P.

 

 

By: MPM BioVentures III GP, L.P., its General Partner

 

 

By: MPM BioVentures III LLC, its General Partner

 

 

 

 

 

By:

/s/ Ansbert K. Gadicke

 

 

 

Ansbert K. Gadicke, Series A Member

 

 

 

 

 

MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC

 

 

 

 

 

By:

/s/ Ansbert K. Gadicke

 

 

 

Ansbert K. Gadicke, Manager

 

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 



 

 

MPM BIO IV NVS STRATEGIC FUND, L.P.

 

 

By: MPM BioVentures IV GP LLC, its General Partner

 

 

By: MPM BioVentures IV LLC, its Managing Member

 

 

 

 

 

By:

/s/ Ansbert K. Gadicke

 

 

 

Ansbert K. Gadicke, Member

 

 

 

 

 

 

 

 

BB BIOTECH VENTURES II, L.P.

 

 

 

 

 

 

 

 

By:

/s/ Pascal Mahieux

 

 

Name: Pascal Mahieux

 

 

Title:

 

 

 

 

 

BB BIOTECH GROWTH N.V.

 

 

 

 

 

 

 

 

By:

/s/ H.J. van Neutegem

 

 

Name: H.J. van Neutegem

 

 

Title: Managing Director

 

 

 

 

 

BROOKSIDE CAPITAL PARTNERS FUND, L.P.

 

 

 

 

 

 

 

 

By:

/s/ Ranesh Ramanathan

 

 

Name: Ranesh Ramanathan

 

 

Title: General Counsel

 

 

 

 

 

 

 

 

THE WELLCOME TRUST LIMITED,

 

 

AS TRUSTEE OF THE WELLCOME TRUST

 

 

 

 

 

 

 

 

By:

/s/ Peter J. Pereira Gray

 

 

Name: Peter J. Pereira Gray

 

 

Title: Managing Director, Investment Division

 

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 



 

OBP IV — HOLDINGS LLC

 

 

By: OBP Management IV, L.P.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Jonathan J. Fleming

 

 

Name: Jonathan J. Fleming

 

 

Title: General Partner

 

 

 

 

 

 

 

 

 

 

MRNA II - HOLDINGS LLC

 

 

By: OBP Management IV, L.P.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Jonathan J. Fleming

 

 

Name: Jonathan J. Fleming

 

 

Title: General Partner

 

 

 

 

 

 

 

 

 

 

HEALTHCARE VENTURES VII, LP,

 

 

By: HealthCare Partners VII, L.P.

 

 

Its General Partner

 

 

 

 

 

 

By:

/s/ Jeffrey Steinberg

 

 

Name: Jeffrey Steinberg

 

 

Title: Administrative Partner of HealthCare Partners VII, L.P.

 

 

The General Partner of HealthCare Ventures VII, L.P.

 

 

 

 

 

 

 

 

 

 

/s/ Raymond F. Schniazi

 

 

Dr. Raymond F. Schinazi

 

 

 

 

 

 

 

 

HEALTHCARE PRIVATE EQUITY LIMITED PARTNERSHIP

 

 

By: Waverley Healthcare Private Equity

 

 

Limited, its general partner

 

 

 

 

 

 

By:

/s/ Archie Struthers

 

 

Name: Archie Struthers

 

 

Title: Director

 

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 



 

The Breining Family Trust dated August 15, 2003

 

 

 

 

 

 

 

 

 

 

By:

/s/ Clifford Breining

 

 

Name: Clifford Breining

 

 

Title: Trustee

 

 

 

 

 

 

 

 

/s/ Dennis Carson

 

 

Dr. Dennis A. Carson

 

 

 

 

 

 

 

 

David E. Thompson Revocable Trust

 

 

 

 

 

 

 

 

 

 

By:

/s/ David E. Thompson

 

 

Name: David E. Thompson

 

 

Title: Trustee

 

 

 

 

 

 

 

 

Jonnie K. Westbrook Revocable Trust dated March 17, 2000

 

 

 

 

 

 

 

 

 

 

By:

/s/ Jonnie K. Westbrook

 

 

Name: Jonnie K. Westbrook

 

 

Title: Trustee

 

 

 

 

 

 

 

 

H. Watt Gregory Watt

 

 

H. Watt Gregory III

 

 

 

 

 

 

 

 

Hostetler Family Trust UTD 3/18/92

 

 

 

 

 

 

 

 

 

 

By:

/s/ Karl Y. Hostetler

 

 

Name: Karl Y. Hostetler

 

 

Title: Co-Trustee

 

 

 

 

 

 

By:

/s/ Maragarethe Hostetler

 

 

Name: Margarethe Hostetler

 

 

Title: Co-Trustee

 

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 


 

The Richman Trust dated 2/6/83

 

 

 

 

 

 

By:

/s/ Douglas D. Richman

 

Name:

Douglas D. Richman

 

Title:

Co-Trustee

 

 

 

 

By:

/s/ Eva A. Richman

 

Name:

Eva A. Richman,

 

Title:

Co-Trustee

 

 

 

 

 

Ruff Trust dated l-1-02

 

 

 

 

By:

/s/ F. Bronson van Wyck

 

Name:

F. Bronson Van Wyck

 

Title:

Trustee

 

 

 

 

 

IPSEN PHARMA SAS

 

 

 

 

By:

/s/ Nathalie Joannes

 

Name:

Nathalie Joannes

 

Title:

Executive Vice President, General Counsel

 

 

 

 

 

NORDIC BIOSCIENCE CLINICAL

 

DEVELOPMENT VII A/A

 

 

 

 

 

 

By:

/s/ Thomas Nielsen

 

Name:

Thomas Nielsen

 

Title:

CFO

 

 

 

 

 

/s/ Alwyn Michael Parfitt

 

Alwyn Michael Parfitt, M.D.

 

 

 

 

 

/s/ Barnett Pitzele

 

Barnett Pitzele

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 



 

/s/ Bart Henderson

 

Bart Henderson

 

 

 

 

 

/s/ Benjamin C. Lane

 

Benjamin C. Lane

 

 

 

 

 

BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS

 

 

 

By:

/s/ Michael G. Douglas

 

Name:

Michael G. Douglas, Ph.D.

 

Title:

Director, UAMS BioVentures

 

 

 

 

 

/s/ Brian Nicholas Harvey

 

Brian Nicholas Harvey

 

 

 

 

 

/s/ Cecil Richard Lyttle

 

Cecil Richard Lyttle

 

 

 

 

 

/s/ Charles O’Brien

 

Charles O’Brien, PhD.

 

 

 

/s/ Chris Glass

 

Chris Glass

 

 

 

 

 

/s/ Christopher Miller

 

Christopher Miller

 

 

 

 

 

/s/ Daniel F. McCarthy

 

Daniel F. McCarthy

 

 

 

 

 

/s/ Dotty Paquin

 

Dotty Paquin

 

 

 

 

 

/s/ Edith Estabrook

 

Edith Estabrook

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 



 

/s/ Elizabeth Czerepak

 

Elizabeth Czerepak

 

 

 

 

 

/s/ Gary Hattersley

 

Gary Hattersley

 

 

 

 

 

H2 ENTERPRISES, LLC

 

 

 

 

By:

/s/ H. Watt Gregory, III

 

Name:

H. Watt Gregory, III

 

Title:

Managing Member

 

 

 

 

 

Dr. John Potts, Jr and Susanne K. Potts

 

Irrevocable Trust for Stephen K. Potts

 

dated 6-15-05

 

 

 

 

 

 

By:

/s/ John T. Potts

 

Name:

John T. Potts Jr. M.D.

 

Title:

Director of Research & Physician-in Chief-Emeritus, Massachusetts General Hospital

 

 

 

 

/s/ John Thomas Potts

 

John Thomas Potts, M.D.

 

 

 

 

 

/s/ John A. Katzenellenbogen

 

John A. Katzenellenbogen, PhD.

 

 

 

 

 

John A. Katzenellenbogen Trust

 

Under Agreement Dated August 2, 1999

 

 

 

 

By:

/s/ John A. Katzenellenbogen

 

Name:

John A. Katzenellenbogen

 

Title:

Trustee

 

 

 

 

 

/s/ Benita S. Katzenellenbogen

 

Benita S. Katzenellenbogen, PhD

 

 

 

/s/ E. Kelly Sullivan

 

E. Kelly Sullivan

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 



 

/s/ Jonathan Guerriero

 

Jonathan Guerriero

 

 

 

 

 

/s/ Julianne Glowacki

 

Julianne Glowacki

 

 

 

 

 

/s/ Kathy Welch

 

Kathy Welch

 

 

 

 

 

/s/ Kelly Colbourn

 

Kelly Colbourn

 

 

 

 

 

/s/ Louis O’ Dea

 

Louis O’Dea

 

 

 

 

 

/s/ Maria Grunwald

 

Maria Grunwald

 

 

 

 

 

/s/ Mary Lumpkins

 

Mary Lumpkins

 

 

 

 

 

/s/ Maysoun Shomali

 

Maysoun Shomali

 

 

 

 

 

/s/ Micahel Rosenblatt

 

Michael Rosenblatt, M.D.

 

 

 

 

 

/s/ Patricia Rosenblatt

 

Patricia E. Rosenblatt

 

 

 

 

 

/s/ Robert L. Jilka

 

Robert L. Jilka, PhD.

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 



 

/s/ Robert S. Weinstein

 

Robert S. Weinstein, M.D.

 

 

 

 

 

/s/ Samuel Ho

 

Samuel Ho

 

 

 

 

 

/s/ Socrates E. Papaoulous

 

Socrates E. Papapoulos, M.D.

 

 

 

 

 

/s/ Stavros C. Manolagas

 

Stavros C. Manolagas

 

 

 

 

 

/s/ Stavroula Kousteni

 

Stavroula Kousteni, PhD.

 

 

 

/s/ Teresita M. Bellido

 

Teresita M. Bellido, PhD.

 

 

 

 

 

/s/ Thomas E. Sparks

 

Thomas E. Sparks

 

 

 

 

 

/s/ Tonya D. Goss

 

Tonya D. Goss

 

 

 

The Kent C. Westbrook Revocable Trust,

 

Dated March 17, 2000,

 

Kent C. Westbrook, Trustee

 

 

 

 

By:

/s/ Kent C. Westbrook

 

Name:

Kent C. Westbrook

 

Title:

Trustee

 

 

 

 

 

GE CAPITAL EQUITY INVESTMENTS, INC.

 

 

 

 

 

 

By:

/s/ Jacqueline Blechinger

 

Name:

Jacqueline Blechinger

 

Title:

Duly Authorized Signatory

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]

 



 

OXFORD FINANCE LLC

 

 

 

 

 

 

By:

/s/ John G. Henderson

 

Name:

John G. Henderson

 

Title:

Vice President & General Counsel

 

 

 

 

 

LEERINK SWANN LLC

 

 

 

 

 

 

By:

/s/ Donald D. Notman

 

Name:

Donald D. Notman

 

Title:

Managing Director

 

 

 

 

 

SVB FINANCIAL GROUP

 

 

 

 

 

 

By:

/s/ Michael Kruse

 

Name:

Michael Kruse

 

Title:

Treasurer

 

 

[Signature page to Amendment No. 2 to Amended and Restated Stockholders’ Agreement]